Elevated ERα levels, together with increased coactivators such as SRC-2 and SRC-3, may enhance steroid hormone sensitivity and transcriptional activity in the endometrium, thereby contributing to the progression of PCOS-associated endometrial dysfunction. The gene discussed is ESR1; the disease is polycystic ovary syndrome.